Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment

Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment

PurposeAccurate risk stratification can improve lymphoma management, but current volumetric 18F-fluorodeoxyglucose (FDG) indicators require time-consuming segmentation of all lesions in the body. Herein, we investigated the prognostic values of readily obtainable metabolic bulk volume (MBV) and bulk...

Full description

Bibliographic Details
Main Authors:	Hyun Jin, Myung Jin, Chae Hong Lim, Joon Young Choi, Seok-Jin Kim, Kyung-Han Lee
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Oncology
Subjects:	lymphoma DLBCL PET/CT (18)F-FDG bulky metabolic tumor volume
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1186311/full

Similar Items

Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma
by: Heejune So, et al.
Published: (2023-11-01)

A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT
by: Lars C. Gormsen, et al.
Published: (2019-05-01)

Characterization of Mediastinal Bulky Lymphomas with FDG-PET-Based Radiomics and Machine Learning Techniques
by: Elisabetta Maria Abenavoli, et al.
Published: (2023-03-01)

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report
by: Lars Kurch, et al.
Published: (2022-01-01)

The clinical challenge of relapsed diffuse large B-cell lymphoma with disseminated infection
by: Suek Chern Goh, MD, et al.
Published: (2023-09-01)

P.67 The Effects of Chemotherapy on Arterial Inflammation Assessed by ¹⁸FDG PET-CT in Patients with Lymphoma
by: Constantinos Anagnostopoulos, et al.
Published: (2020-12-01)

Beyond lymph nodes: 18F-FDG PET/CT in detection of unusual sites of extranodal lymphoma
by: Amal Ibrahim Ahmed Othman, et al.
Published: (2019-09-01)

Significance of bulky mass and residual tumor—Treated with or without consolidative radiotherapy—To the risk of relapse in DLBCL patients
by: Susanna Tokola, et al.
Published: (2020-03-01)

Diagnostic Accuracy of PET/CT in Detecting Aggressiveness of Lymphoma Based on Sub Uptake
by: Sana waqar, et al.
Published: (2023-04-01)

Diagnostic performance of prospective same-day 18F-FDG PET/MRI and 18F-FDG PET/CT in the staging and response assessment of lymphoma
by: Vijay Mistry, et al.
Published: (2023-01-01)

Gallbladder Involvement of Diffuse Large B-Cell Lymphoma with 18F-FDG PET/CT
by: Esra Arslan, et al.
Published: (2022-05-01)

New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT
by: Anne-Ségolène Cottereau, et al.
Published: (2021-08-01)

A case of peritoneal Burkitt's lymphoma mimic of peritoneal tuberculosis
by: Bei Feng, et al.
Published: (2024-01-01)

The role of 18F-FDG PET/CT in evaluation of Primary CNS lymphoma: The path less travelled
by: Sharjeel Usmani, et al.
Published: (2023-07-01)

Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma
by: Melikşah Bayar, et al.
Published: (2021-05-01)

Clinical features and 18F-FDG PET/CT for distinguishing of malignant lymphoma from inflammatory lymphadenopathy in HIV-infected patients
by: Donghe Chen, et al.
Published: (2022-07-01)

Prognostic evaluation of extranodal natural killer/T-cell lymphoma, nasal type(ENKTL) with 18F-FDG PET/CT
by: WANG Jin, GUO Rui, LI Biao, ZHANG Xiaozhe
Published: (2022-12-01)

Follicular lymphoma presenting as a seminal vesicle mass: Diagnostic path from prostate MRI to 18F-FDG PET/CT
by: Burcin Agridag Ucpinar, MD, et al.
Published: (2023-08-01)

Significance of metabolic parameters and biochemical indexes of 18F-FDG PET/CT in the mid-term evaluation and prognosis of diffuse large B-cell lymphoma
by: Zhang Fan, Zhang Guoxu, Liu Xiuting, Wang Jigang, Liu Yanqin, Tong Danjiang, Liu Jinghua, Zhou Fan
Published: (2022-03-01)

Clinical Features and Immunophenotypes of Double-Hit Diffuse Large B-Cell Lymphoma
by: Cheng-Han Wu, et al.
Published: (2022-04-01)

Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma
by: Shama Jaswal, et al.
Published: (2022-06-01)

Comparison between RECIST and PERCIST criteria in therapeutic response assessment in cases of lymphoma
by: Marwa Mohammed Hasan Tawfik, et al.
Published: (2020-05-01)

Comparison of 18F-FDG PET/CT and conventional methods in diagnosing extranodal natural killer/T-cell lymphoma
by: Huixia Geng, et al.
Published: (2024-01-01)

Two-Year Event-Free Survival Prediction in DLBCL Patients Based on In Vivo Radiomics and Clinical Parameters
by: Zsombor Ritter, et al.
Published: (2022-06-01)

Comprehensive analysis of the influence of G-CSF on the biodistribution of 18F-FDG in lymphoma patients: insights for PET/CT scheduling
by: Magno Oliveira, et al.
Published: (2019-08-01)

Combatting the effect of image reconstruction settings on lymphoma [18F]FDG PET metabolic tumor volume assessment using various segmentation methods
by: Maria C. Ferrández, et al.
Published: (2022-07-01)

Review of Treatment Options for the Management of Advanced Stage Hodgkin Lymphoma
by: Hélène Vellemans, et al.
Published: (2021-07-01)

A Rare Case of Radiation-Induced Liver Disease in Treated Abdominal Lymphoma Showing High [<sup>18</sup>F]FDG Avidity and Low EOB Uptake Proportional to the Irradiation Dose
by: Aya Usami, et al.
Published: (2022-02-01)

The Prognostic Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients
by: Cong Li, et al.
Published: (2022-05-01)

Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report
by: Alberto Nieri, et al.
Published: (2023-06-01)

Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT
by: Hongyan Li, et al.
Published: (2022-07-01)

[18F]FDG-PET/CT Radiomics for Prediction of Bone Marrow Involvement in Mantle Cell Lymphoma: A Retrospective Study in 97 Patients
by: Marius E. Mayerhoefer, et al.
Published: (2020-05-01)

Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments
by: S. Jemaa, et al.
Published: (2022-08-01)

The prognostic value of pretreatment 18F-FDG PET/CT in extranodal natural killer/T-cell lymphoma
by: FENG Guowei, ZHANG Xiaojuan, GUO Rui, GUAN Zhe, WANG Yue
Published: (2021-12-01)

The Role of 18F-FDG PET/CT in Staging and Prognostication of Mantle Cell Lymphoma: An Italian Multicentric Study
by: Domenico Albano, et al.
Published: (2019-11-01)

Angiogenesis imaging study using interim [18F] RGD-K5 PET/CT in patients with lymphoma undergoing chemotherapy: preliminary evidence
by: David Tonnelet, et al.
Published: (2021-04-01)

Prognostic value of the combination of volume, massiveness and fragmentation parameters measured on baseline FDG pet in high-burden follicular lymphoma
by: S. Draye-Carbonnier, et al.
Published: (2024-04-01)

<sup>18</sup>F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
by: Domenico Albano, et al.
Published: (2023-04-01)

A preliminary investigation of the relationship between 18F-FDG PET/CT metabolic parameters and prognosis in angioimmunoblastic T-cell lymphoma
by: Lanping Hu, et al.
Published: (2023-06-01)

Baseline <sup>18</sup>F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions
by: Elizabeth Katherine Anna Triumbari, et al.
Published: (2023-04-01)